Related Experiment Videos
[Adult multi-nuclear cell hepatitis. A study in 17 patients]
T Tordjmann1, S Grimbert, C Genestie
1Service d'Hépato-Gastroentérologie, Hôpital Jean-Verdier, Bondy.
Gastroenterologie Clinique Et Biologique
|October 8, 1998
Summary
Giant-cell hepatitis in adults is rare, often without a clear cause. Early immunosuppressive treatment may improve outcomes for patients with this condition, as it can progress to cirrhosis.
Area of Science:
- Hepatology
- Immunology
- Pathology
Background:
- Giant-cell hepatitis is a rare liver condition in adults with unclear significance.
- This study investigates the clinical and histological features and outcomes of adult patients diagnosed with giant-cell hepatitis.
Purpose of the Study:
- To characterize the clinical presentation, histological findings, and prognosis of giant-cell hepatitis in adult patients.
- To evaluate the potential role of immunosuppressive therapy in managing this condition.
Main Methods:
- Retrospective analysis of 17 adult patients with giant-cell hepatitis (defined by biopsy criteria).
- Evaluation of clinical, biochemical, histological, and serological data (including viral markers).
- Immunohistochemistry for paramyxovirus was performed on liver biopsies.
Main Results:
- The study included 17 patients (11 female, 6 male; average age 48).
- Etiology was identified in 4 patients (hepatitis B, drug-induced, chronic hepatitis B/C with AIDS). In 13 patients, etiology remained undetermined, with 8 showing acute and 5 chronic hepatitis.
- Nine patients received immunosuppressive drugs; 8 responded, but 5 progressed to cirrhosis. Two untreated patients with unexplained disease died from liver failure.
Conclusions:
- Giant-cell hepatitis in adults, especially with unidentified causes, may follow a course similar to autoimmune hepatitis.
- The observed poor prognosis suggests that early immunosuppressive treatment is warranted for these patients.